The Immune Atlas identifies immune signatures in MM, enhancing outcome prediction and guiding personalized therapies by ...
Trained immunity provides a unifying framework linking innate immune memory to both protective and maladaptive inflammation ...
Artiva Biotherapeutics is developing NK cell immunotherapy for autoimmune disease. Early trial data in B-cell lymphoma ...
ImmunityBio, Inc. (NASDAQ: IBRX), a vertically-integrated commercial stage biotechnology company, announced today preliminary ...
A historic corruption scandal simmered in plain sight for more than a year while the sport’s power structure chose indifference over integrity.
News-Medical.Net on MSN
Breast milk shares beneficial bacteria with babies
The gut and breast milk microbiomes both harbored antimicrobial resistance genes (ARGs) with distinct diversity and ...
Investing.com -- ImmunityBio (NASDAQ:IBRX) stock surged 28% Thursday after the company reported preliminary 2025 net product ...
Study Finds on MSN
Astronauts’ bodies aged by 2 years after 9 days in space, then became ‘younger’ hours after return to Earth
One astronaut became younger than before the trip, and maintained lower biological age through a follow-up period. In A ...
The US president vowed to ‘end childhood cancer’. But his administration is dismantling the search for a cure and sending families scrambling for treatment ...
ImmunityBio (IBRX) stock jumps as Saudi regulators approve the company's bladder cancer drug Anktiva and enrollments in QUILT ...
Researchers at the Buck Institute used Axiom-2 blood samples to show spaceflight temporarily accelerated epigenetic aging, ...
Approval of ANKTIVA was granted for BCG-unresponsive non-muscle-invasive bladder cancer (NMIBC) with carcinoma in situ, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback